Delivery Order SPE2DB20D1051-SPE2DB25FD9HF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 20 mg tablets (30-count packages) with a ceiling value of $1,095.72. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $2,121.12 to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Telmisartan is an antihypertensive medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Telmisartan 40 mg tablets in quantities of 30 units, with a ceiling value of $6,548.33 and an ultimate completion date of January 14, 2026. This delivery order was competitively awarded with no set-aside designation and represents a task order under a larger Indefinite Delivery Contract vehicle. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) with a ceiling value of $5,015.84 under a firm fixed-price contract. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on November 25, 2025, for Telmisartan 20 mg tablets (30-count) with a ceiling value of $1,503.87. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order is set for ultimate completion by November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) under a firm fixed price contract valued at $1,264.14. This non-set-aside award was executed on October 30, 2025, with an ultimate completion date of October 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $5,906.90 under a firm fixed-price contract. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor with performance of the work also occurring at...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9HFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 20 mg tablets (quantity 30s) with a firm fixed price ceiling value of $1,223.12. This non-set-aside award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract provides comprehensive pharmaceutical support to military healthcare systems and other federal agencies, enabling flexible procurement of medications, vaccines, and medical supplies across multiple therapeutic categories. The current award for Telmisartan, an antihypertensive medication, exemplifies the routine pharmaceutical deliveries executed under this broad-based vehicle to support Defense Health Agency operations and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/5/25 |